price to sales ratio, page-2

That is a great question, I think it is dependent on a number of variables.

• Hype – often this is dictated by investors and popularity.
• Forecasted growth – This will grow in the next 12 months
• Maturity / potential of the company – This will grow in the next 12 months

 

I do believe that ALC has a significant re-rate in store. However, there needs to be a realisation from new investors of who/what we do at the end of the day.

 

A realisation is also needed on the whole Health IT sector imo.